Epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040
- PMID: 36482832
- PMCID: PMC9807450
- DOI: 10.1111/1759-7714.14745
Epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040
Abstract
Esophageal cancer is a familiar malignancy with high incidence and mortality, and the overall prognosis is poor. The numbers of cases of and deaths from esophageal cancer have risen rapidly in recent decades. It is one of the most malignant cancers, with more than 0.6 million new cases and 0.54 million deaths worldwide in 2020. Here, we present the global epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040 at different geographical levels of continents, regions and countries, and analyze them by gender, race, geographic region and human development index. We summarize the prospects for the esophageal cancer burden and risk factors in different areas, which will be useful for global esophageal cancer clinical therapy and cancer control planning.
Keywords: esophageal cancer; incidence; mortality; projection.
© 2022 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
Conflict of interest statement
There are no conflict of interest for this article.
Figures





Similar articles
-
Global trends in the incidence and mortality of esophageal cancer from 1990 to 2017.Cancer Med. 2020 Sep;9(18):6875-6887. doi: 10.1002/cam4.3338. Epub 2020 Aug 4. Cancer Med. 2020. PMID: 32750217 Free PMC article.
-
Global trends in esophageal cancer.J Surg Oncol. 2017 Apr;115(5):564-579. doi: 10.1002/jso.24592. Epub 2017 Mar 20. J Surg Oncol. 2017. PMID: 28320055
-
Epidemiological landscape of esophageal cancer in Asia: Results from GLOBOCAN 2020.Thorac Cancer. 2023 Apr;14(11):992-1003. doi: 10.1111/1759-7714.14835. Epub 2023 Mar 14. Thorac Cancer. 2023. PMID: 36918204 Free PMC article.
-
Epidemiology of esophageal cancer: update in global trends, etiology and risk factors.Clin J Gastroenterol. 2020 Dec;13(6):1010-1021. doi: 10.1007/s12328-020-01237-x. Epub 2020 Sep 23. Clin J Gastroenterol. 2020. PMID: 32965635 Review.
-
Epidemiology and clinical aspects of esophageal cancer.J Belge Radiol. 1991;74(5):365-8. J Belge Radiol. 1991. PMID: 1665845 Review.
Cited by
-
Unraveling the puzzle: efficacy of PD-L1 inhibitors in esophageal squamous cell carcinomas with low PD-L1 expression-a comprehensive overview of challenges and limitations.Transl Cancer Res. 2023 Dec 31;12(12):3245-3248. doi: 10.21037/tcr-23-1117. Epub 2023 Nov 24. Transl Cancer Res. 2023. PMID: 38192985 Free PMC article. No abstract available.
-
Feasibility and Safety of PD-1 Blockades Among Elderly Patients with Metastatic Esophageal Squamous Cell Carcinoma: A Real-World Study.Drug Des Devel Ther. 2024 Sep 16;18:4135-4151. doi: 10.2147/DDDT.S476457. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 39308693 Free PMC article.
-
MVNMDA: A Multi-View Network Combing Semantic and Global Features for Predicting miRNA-Disease Association.Molecules. 2023 Dec 31;29(1):230. doi: 10.3390/molecules29010230. Molecules. 2023. PMID: 38202814 Free PMC article.
-
A Comprehensive Analysis of Tn and STn Antigen Expression in Esophageal Adenocarcinoma.Cancers (Basel). 2024 Jan 5;16(2):240. doi: 10.3390/cancers16020240. Cancers (Basel). 2024. PMID: 38254730 Free PMC article.
-
Management of early oesophageal cancer: An overview.World J Gastrointest Surg. 2024 May 27;16(5):1255-1258. doi: 10.4240/wjgs.v16.i5.1255. World J Gastrointest Surg. 2024. PMID: 38817272 Free PMC article.
References
-
- Collaborators GBDOC . The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990‐2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol. 2020;5(6):582–97. 10.1016/S2468-1253(20)30007-8 - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical